Intel (INTC) 10-Q 24 Jul 20 2020 Q2 Quarterly report Financial data

Cover Page

Cover Page shares in Millions	6 Months Ended
	Jun. 27, 2020shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 27, 2020
Entity File Number	000-06217
Entity Registrant Name	INTEL CORPORATION
Entity Central Index Key	0000050863
Current Fiscal Year End Date	--12-26
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1672743
Entity Address, Address Line One	2200 Mission College Boulevard,
Entity Address, City or Town	Santa Clara,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1549
City Area Code	(408)
Local Phone Number	765-8080
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	INTC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	4,253

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Income Statement [Abstract]
Net revenue	$ 19,728	$ 16,505	$ 39,556	$ 32,566
Cost of sales	9,221	6,627	17,033	13,599
Gross margin	10,507	9,878	22,523	18,967
Research and development	3,354	3,438	6,629	6,770
Marketing, general and administrative	1,447	1,639	2,988	3,222
Restructuring and other charges	9	184	171	184
Operating expenses	4,810	5,261	9,788	10,176
Operating income	5,697	4,617	12,735	8,791
Gains (losses) on equity investments, net	267	170	156	604
Interest and other, net	(29)	(63)	(342)	(124)
Income before taxes	5,935	4,724	12,549	9,271
Provision for taxes	830	545	1,783	1,118
Net income	$ 5,105	$ 4,179	$ 10,766	$ 8,153
Earnings per share - Basic (in dollars per share)	$ 1.20	$ 0.94	$ 2.53	$ 1.82
Earnings per share - Diluted (in dollars per share)	$ 1.19	$ 0.92	$ 2.50	$ 1.79
Weighted average shares of common stock outstanding:
Basic (shares)	4,246	4,466	4,256	4,479
Diluted (shares)	4,284	4,523	4,298	4,543

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 5,105	$ 4,179	$ 10,766	$ 8,153
Changes in other comprehensive income, net of tax:
Net unrealized holding gains (losses) on derivatives	319	151	51	253
Actuarial valuation and other pension benefits (expenses), net	11	8	23	17
Translation adjustments and other	59	32	54	82
Other comprehensive income (loss)	389	191	128	352
Total comprehensive income	$ 5,494	$ 4,370	$ 10,894	$ 8,505

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Jun. 27, 2020	Dec. 28, 2019
Current assets:
Cash and cash equivalents	$ 8,736	$ 4,194
Short-term investments	4,791	1,082
Trading assets	12,288	7,847
Accounts receivable	7,441	7,659
Inventories	8,969	8,744
Other current assets	2,165	1,713
Total current assets	44,390	31,239
Property, plant and equipment, net of accumulated depreciation of $77,988 ($73,321 as of December 28, 2019)	58,036	55,386
Equity Investments	3,901	3,967
Other long-term investments	2,884	3,276
Goodwill	26,943	26,276
Identified intangible assets, net	10,303	10,827
Other long-term assets	6,082	5,553
Total assets	152,539	136,524
Current liabilities:
Short-term debt	2,254	3,693
Accounts payable	5,045	4,128
Accrued compensation and benefits	2,833	3,853
Other accrued liabilities	12,349	10,636
Total current liabilities	22,481	22,310
Debt	36,093	25,308
Contract Liabilities	1,329	1,368
Income taxes payable, non-current	4,795	4,919
Deferred income taxes	2,723	2,044
Other long-term liabilities	3,108	2,916
Contingencies (Note 13)
Temporary equity	0	155
Stockholders’ equity:
Preferred stock	0	0
Common stock and capital in excess of par value, 4,253 issued and outstanding (4,290 issued and outstanding as of December 28, 2019)	25,516	25,261
Accumulated other comprehensive income (loss)	(1,152)	(1,280)
Retained earnings	57,646	53,523
Total stockholders’ equity	82,010	77,504
Total liabilities, temporary equity, and stockholders’ equity	$ 152,539	$ 136,524

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Jun. 27, 2020	Dec. 28, 2019
Assets
Accumulated depreciation	$ 77,988	$ 73,321
Stockholders’ equity:
Common stock, shares issued	4,253	4,290
Common stock, shares outstanding	4,253	4,290

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019
Statement of Cash Flows [Abstract]
Cash and cash equivalents, beginning of period	$ 4,194	$ 3,019
Cash flows provided by (used for) operating activities:
Net income	10,766	8,153
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	5,248	4,379
Share-based compensation	941	859
Amortization of intangibles	865	800
(Gains) losses on equity investments, net	(92)	(100)
Changes in assets and liabilities:
Accounts receivable	224	490
Inventories	(271)	(1,443)
Accounts payable	208	431
Accrued compensation and benefits	(919)	(1,012)
Prepaid supply agreements	(161)	(444)
Income taxes	1,203	(15)
Other assets and liabilities	(697)	448
Total adjustments	6,549	4,393
Net cash provided by operating activities	17,315	12,546
Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment	(6,676)	(6,875)
Purchases of available-for-sale debt investments	(4,558)	(1,721)
Maturities and sales of available-for-sale debt investments	1,303	2,031
Purchases of trading assets	(11,429)	(4,498)
Maturities and sales of trading assets	7,430	3,808
Sales of equity investments	186	1,331
Other investing	(602)	(86)
Net cash used for investing activities	(14,346)	(6,010)
Cash flows provided by (used for) financing activities:
Increase (decrease) in short-term debt, net	0	996
Issuance of long-term debt, net of issuance costs	10,247	601
Repayment of debt and debt conversion	(2,775)	(1,033)
Proceeds from sales of common stock through employee equity incentive plans	512	305
Repurchase of common stock	(4,229)	(5,579)
Payment of dividends to stockholders	(2,811)	(2,828)
Other financing	629	850
Net cash provided by (used for) financing activities	1,573	(6,688)
Net increase (decrease) in cash and cash equivalents	4,542	(152)
Cash and cash equivalents, end of period	8,736	2,867
Supplemental disclosures of noncash investing activities and cash flow information:
Acquisition of property, plant, and equipment included in accounts payable and accrued liabilities	2,836	2,678
Interest, net of capitalized interest	252	243
Income taxes, net of refunds	$ 574	$ 1,112

Consolidated Condensed Statem_4

Consolidated Condensed Statements of Stockholders' Equity Statement - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Capital in Excess of Par Value	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Total stockholders' equity, beginning at Dec. 29, 2018	$ 74,563	$ 25,365	$ (974)	$ 50,172
Common stock, shares outstanding, beginning (in shares) at Dec. 29, 2018		4,516
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,153			8,153
Other comprehensive income (loss)	352		352
Employee equity incentive plans and other	403	$ 403
Employee equity incentive plans (in shares)		38
Share-based compensation	860	$ 860
Temporary equity reduction	173	173
Convertible debt	(712)	(712)
Repurchase of common stock	(5,595)	$ (659)		(4,936)
Repurchase of common stock (in shares)		(116)
Restricted stock unit withholdings	(421)	$ (290)		(131)
Restricted stock unit withholdings (in shares)		(8)
Cash dividends declared	(2,829)			(2,829)
Total stockholders' equity, ending at Jun. 29, 2019	74,947	$ 25,140	(622)	50,429
Common stock, shares outstanding, ending (in shares) at Jun. 29, 2019		4,430
Total stockholders' equity, beginning at Mar. 30, 2019	73,661	$ 25,346	(813)	49,128
Common stock, shares outstanding, beginning (in shares) at Mar. 30, 2019		4,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,179			4,179
Other comprehensive income (loss)	191		191
Employee equity incentive plans and other	31	$ 31
Employee equity incentive plans (in shares)		27
Share-based compensation	471	$ 471
Temporary equity reduction	28	28
Convertible debt	(120)	(120)
Repurchase of common stock	(3,145)	$ (381)		(2,764)
Repurchase of common stock (in shares)		(67)
Restricted stock unit withholdings	(349)	$ (235)		(114)
Restricted stock unit withholdings (in shares)		(7)
Total stockholders' equity, ending at Jun. 29, 2019	74,947	$ 25,140	(622)	50,429
Common stock, shares outstanding, ending (in shares) at Jun. 29, 2019		4,430
Total stockholders' equity, beginning at Dec. 28, 2019	$ 77,504	$ 25,261	(1,280)	53,523
Common stock, shares outstanding, beginning (in shares) at Dec. 28, 2019	4,290	4,290
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 10,766			10,766
Other comprehensive income (loss)	128		128
Employee equity incentive plans and other	629	$ 629
Employee equity incentive plans (in shares)		42
Share-based compensation	941	$ 941
Temporary equity reduction	155	155
Convertible debt	(750)	(750)
Repurchase of common stock	(4,109)	$ (420)		(3,689)
Repurchase of common stock (in shares)		(71)
Restricted stock unit withholdings	(435)	$ (300)		(135)
Restricted stock unit withholdings (in shares)		(8)
Cash dividends declared	(2,819)			(2,819)
Total stockholders' equity, ending at Jun. 27, 2020	$ 82,010	$ 25,516	(1,152)	57,646
Common stock, shares outstanding, ending (in shares) at Jun. 27, 2020	4,253	4,253
Total stockholders' equity, beginning at Mar. 28, 2020	$ 76,354	$ 25,251	(1,541)	52,644
Common stock, shares outstanding, beginning (in shares) at Mar. 28, 2020		4,234
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,105			5,105
Other comprehensive income (loss)	389		389
Employee equity incentive plans and other	9	$ 9
Employee equity incentive plans (in shares)		25
Share-based compensation	492	$ 492
Temporary equity reduction	0	0
Convertible debt	0	0
Repurchase of common stock	0	$ 0		0
Repurchase of common stock (in shares)		0
Restricted stock unit withholdings	(339)	$ (236)		(103)
Restricted stock unit withholdings (in shares)		(6)
Total stockholders' equity, ending at Jun. 27, 2020	$ 82,010	$ 25,516	$ (1,152)	$ 57,646
Common stock, shares outstanding, ending (in shares) at Jun. 27, 2020	4,253	4,253

Consolidated Condensed Statem_5

Consolidated Condensed Statements of Stockholders' Equity Statements of Stockholders' Equity (Parenthetical) - $ / shares	6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019
Retained Earnings
Common Stock, Dividends, Per Share, Declared	$ 0.66	$ 0.63

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 27, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Text Block]	NOTE 1 : BASIS OF PRESENTATION We prepared our interim Consolidated Condensed Financial Statements that accompany these notes in conformity with U.S. GAAP, consistent in all material respects with those applied in our 2019 Form 10-K. We have made estimates and judgments affecting the amounts reported in our Consolidated Condensed Financial Statements and the accompanying notes. The inputs into our judgments and estimates consider the economic implications of COVID-19 on our critical and significant accounting estimates. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with the Consolidated Financial Statements in our 2019 Form 10-K where we include additional information about our policies and the methods and assumptions used in our estimates.

Operating Segments

Operating Segments	6 Months Ended
	Jun. 27, 2020
Segment Reporting [Abstract]
Operating Segments [Text Block]	NOTE 2 : OPERATING SEGMENTS We manage our business through the following operating segments: • DCG • IOTG • Mobileye • NSG • PSG • CCG We derive a substantial majority of our revenue from platform products, which are our principal products and considered as one class of product. We offer platform products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone SoC, or a multichip package. Platform products are used in various form factors across our DCG, IOTG, and CCG operating segments. Our non-platform, or adjacent products, can be combined with platform products to form comprehensive platform solutions to meet customer needs. DCG and CCG are our reportable operating segments. IOTG, Mobileye, NSG, and PSG do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. Our Internet of Things portfolio, presented as Internet of Things, is comprised of IOTG and Mobileye operating segments. We have an “all other” category that includes revenue, expenses, and charges such as: • results of operations from non-reportable segments not otherwise presented; • historical results of operations from divested businesses; • results of operations of start-up businesses that support our initiatives, including our foundry business; • amounts included within restructuring and other charges; • a portion of employee benefits, compensation, and other expenses not allocated to the operating segments; and • acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill. The CODM, who is our CEO, does not evaluate operating segments using discrete asset information. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. The accounting policies for segment reporting are the same as for Intel as a whole. Net revenue and operating income (loss) for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Net revenue: Data Center Group Platform $ 6,181 $ 4,553 $ 12,608 $ 9,035 Adjacent 936 430 1,502 850 7,117 4,983 14,110 9,885 Internet of Things IOTG 670 986 1,553 1,896 Mobileye 146 201 400 410 816 1,187 1,953 2,306 Non-Volatile Memory Solutions Group 1,659 940 2,997 1,855 Programmable Solutions Group 501 489 1,020 975 Client Computing Group Platform 8,229 7,925 16,941 15,749 Adjacent 1,267 916 2,330 1,678 9,496 8,841 19,271 17,427 All other 139 65 205 118 Total net revenue $ 19,728 $ 16,505 $ 39,556 $ 32,566 Operating income (loss): Data Center Group $ 3,099 $ 1,800 6,591 $ 3,641 Internet of Things IOTG 70 294 313 545 Mobileye (4) 53 84 121 66 347 397 666 Non-Volatile Memory Solutions Group 322 (284) 256 (581) Programmable Solutions Group 80 52 177 141 Client Computing Group 2,842 3,737 7,067 6,809 All other (712) (1,035) (1,753) (1,885) Total operating income $ 5,697 $ 4,617 $ 12,735 $ 8,791 Disaggregated net revenue for each period was as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Platform revenue DCG platform $ 6,181 $ 4,553 $ 12,608 $ 9,035 IOTG platform 619 891 1,414 1,716 CCG desktop platform 2,368 2,767 5,208 5,653 CCG notebook platform 5,844 5,136 11,701 10,063 CCG other platform 1 16 22 31 33 15,028 13,369 30,962 26,500 Adjacent revenue 2 4,700 3,136 8,594 6,066 Total revenue $ 19,728 $ 16,505 $ 39,556 $ 32,566 1 Includes our tablet and service provider revenue. 2 Includes all of our non-platform products for DCG, IOTG, and CCG such as modem, Ethernet, and silicon photonics, as well as Mobileye, NSG, and PSG products.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 27, 2020
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 3 : EARNINGS PER SHARE We computed basic earnings per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period. Three Months Ended Six Months Ended (In Millions, Except Per Share Amounts) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Net income available to common stockholders $ 5,105 $ 4,179 $ 10,766 $ 8,153 Weighted average shares of common stock outstanding—basic 4,246 4,466 4,256 4,479 Dilutive effect of employee equity incentive plans 38 40 42 46 Dilutive effect of convertible debt — 17 — 18 Weighted average shares of common stock outstanding—diluted 4,284 4,523 4,298 4,543 Earnings per share—basic $ 1.20 $ 0.94 $ 2.53 $ 1.82 Earnings per share—diluted $ 1.19 $ 0.92 $ 2.50 $ 1.79 Potentially dilutive shares of common stock from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan. In January 2020, we fully redeemed the remaining principal of our 2009 Debentures. We included our 2009 Debentures in the calculation of diluted earnings per share of common stock in 2019 by applying the treasury stock method because the average market price was above the conversion price. Securities which would have been anti-dilutive are insignificant and are excluded from the computation of diluted earnings per share in all periods presented.

Contract Liabilities

Contract Liabilities	6 Months Ended
	Jun. 27, 2020
Revenue from Contract with Customer [Abstract]
Contract Liabilities [Text Block]	NOTE 4 : CONTRACT LIABILITIES (In Millions) Jun 27, 2020 Dec 28, 2019 Prepaid supply agreements $ 1,644 $ 1,805 Other 279 236 Total contract liabilities $ 1,923 $ 2,041 Contract liabilities are primarily related to prepayments received from customers on long-term prepaid supply agreements toward future NSG product delivery. The short-term portion of contract liabilities is reported on the Consolidated Condensed Balance Sheets within other accrued liabilities. The following table shows the changes in contract liability balances relating to long-term prepaid supply agreements during the first six months of 2020: (In Millions) Prepaid supply agreements balance as of December 28, 2019 $ 1,805 Prepayments utilized (161) Prepaid supply agreements balance as of June 27, 2020 $ 1,644 During the second quarter of 2020, we issued a contract termination notification for breach to our largest prepaid supply customer with a $1.6 billion contract liability balance. The timing and amount of future anticipated revenue, or reversal of any contract liability balance, resulting from contract termination may vary due to ongoing customer negotiations.

Other Financial Statement Detai

Other Financial Statement Details	6 Months Ended
	Jun. 27, 2020
Other Financial Statement Details [Abstract]
Other Financial Statement Details [Text Block]	NOTE 5 : OTHER FINANCIAL STATEMENT DETAILS INVENTORIES (In Millions) Jun 27, 2020 Dec 28, 2019 Raw materials $ 903 $ 840 Work in process 6,093 6,225 Finished goods 1,973 1,679 Total inventories $ 8,969 $ 8,744 INTEREST AND OTHER, NET The components of interest and other, net for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Interest income $ 83 $ 125 $ 176 $ 260 Interest expense (186) (135) (321) (273) Other, net 74 (53) (197) (111) Total interest and other, net $ (29) $ (63) $ (342) $ (124) Interest expense in the preceding table is net of $87 million of interest capitalized in the second quarter of 2020 and $170 million in the first six months of 2020 ($120 million in the second quarter of 2019 and $245 million in the first six months of 2019).

Restructuring and Other Charges

Restructuring and Other Charges	6 Months Ended
	Jun. 27, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	NOTE 6 : RESTRUCTURING AND OTHER CHARGES A restructuring program was approved in the first quarter of 2020 to further align our workforce with our continuing investments in the business and to execute the planned divestiture of Home Gateway Platform, a division of CCG. We expect these actions to be substantially complete in the third quarter of 2020. A restructuring program was approved in the second quarter of 2019 to align our workforce with our exit of the smartphone modem business. We expect these actions to be substantially complete in the third quarter of 2020. Restructuring and other charges by type for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Employee severance and benefit arrangements $ 1 $ 168 $ 106 $ 168 Asset impairment and other charges 8 16 65 16 Total restructuring and other charges $ 9 $ 184 $ 171 $ 184

Investments

Investments	6 Months Ended
	Jun. 27, 2020
Investments and Cash [Abstract]
Investments [Text Block]	NOTE 7 : INVESTMENTS DEBT INVESTMENTS Trading Assets For trading assets still held at the reporting date we recorded net gains of $347 million in the second quarter of 2020 and net gains of $183 million in the first six months of 2020 ($99 million of net gains in the second quarter of 2019 and $117 million of net gains in the first six months of 2019). Net losses on the related derivatives were $251 million in the second quarter of 2020 and net losses of $204 million in the first six months of 2020 ($102 million of net losses in the second quarter of 2019 and $104 million of net losses in the first six months of 2019). Available-for-Sale Debt Investments Jun 27, 2020 Dec 28, 2019 (In Millions) Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Corporate debt $ 3,911 $ 94 $ — $ 4,005 $ 2,914 $ 44 $ — $ 2,958 Financial institution 7,985 24 — 8,009 3,007 15 (1) 3,021 Government debt 2,491 12 — 2,503 560 4 — 564 Total available-for-sale debt investments $ 14,387 $ 130 $ — $ 14,517 $ 6,481 $ 63 $ (1) $ 6,543 Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. Substantially all time deposits were issued by institutions outside the U.S. as of June 27, 2020 and December 28, 2019. The fair value of available-for-sale debt investments, by contractual maturity, as of June 27, 2020, was as follows: (In Millions) Fair Value Due in 1 year or less $ 7,763 Due in 1–2 years 1,525 Due in 2–5 years 1,359 Due after 5 years — Instruments not due at a single maturity date 3,870 Total $ 14,517 EQUITY INVESTMENTS (In Millions) Jun 27, 2020 Dec 28, 2019 Marketable equity securities $ 464 $ 450 Non-marketable equity securities 3,419 3,480 Equity method investments 18 37 Total $ 3,901 $ 3,967 The components of gains (losses) on equity investments, net for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Ongoing mark-to-market adjustments on marketable equity securities $ 165 $ (179) $ 62 $ 74 Observable price adjustments on non-marketable equity securities 58 8 137 16 Impairment charges (51) (39) (193) (62) Sale of equity investments and other¹ 95 380 150 576 Total gains (losses) on equity investments, net $ 267 $ 170 $ 156 $ 604 1 Sale of equity investments and other includes realized gains (losses) on sales of non-marketable equity investments, our share of equity method investee gains (losses) and distributions, and initial fair value adjustments recorded upon a security becoming marketable. We recognized higher than historically experienced impairment charges on our non-marketable portfolio in the first six months of 2020 based on our assessment of the impact of recent public and private market volatility and tightening of liquidity. Gains and losses for our marketable and non-marketable equity securities during the period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Net gains (losses) recognized during the period on equity securities $ 223 $ (178) $ 83 $ 84 Less: Net (gains) losses recognized during the period on equity securities sold during the period (55) (33) (58) (258) Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date $ 168 $ (211) $ 25 $ (174) IMFT IMFT was formed in 2006 by Micron Technology, Inc. (Micron) and Intel to jointly develop NAND flash memory and 3D XPoint™ technology products. As of June 29, 2019, we had a carrying value of $1.3 billion in IMFT and owned a 49% interest in the unconsolidated variable interest entity. We sold our non-controlling interest in IMFT to Micron in October 2019. We will continue to purchase product manufactured by Micron at the IMFT facility under supply agreements, which include the next generation of 3D XPoint™ technology.

Acquisitions and Divestitures

Acquisitions and Divestitures	6 Months Ended
	Jun. 27, 2020
Business Combinations [Abstract]
Acquisitions and Divestitures [Text Block]	NOTE 8 : ACQUISITIONS AND DIVESTITURES ACQUISITIONS Acquisition of Moovit On May 4, 2020, we acquired Moovit, a MaaS solutions company, for total consideration of $915 million. The fair values of the assets acquired relate to goodwill of $638 million and intangible assets of $331 million. The goodwill arising from the acquisition is attributed to the expected synergies and other benefits that will be generated from the combination of Intel and Moovit. We expect substantially all of the goodwill will not be deductible for local tax purposes. The acquisition-related intangible assets are primarily related to Moovit's monthly active user base and application platform. The goodwill and operating results of Moovit are included in our Mobileye operating segment. DIVESTITURES Planned Divestiture of our Home Gateway Platform Division We signed a definitive agreement on April 5, 2020 to sell the majority of Home Gateway Platform, a division of CCG. The transaction contemplates the transfer of certain employees, equipment, and an on-going supply agreement for future units. We reclassified the assets and liabilities as held-for-sale within other current assets/liabilities. We expect to close the transaction in the third quarter of 2020.

Borrowings

Borrowings	6 Months Ended
	Jun. 27, 2020
Debt Disclosure [Abstract]
Borrowings	NOTE 9 : BORROWINGS As of June 27, 2020, our short-term debt was $2.3 billion, primarily comprised of the current portion of our long-term debt ($3.7 billion as of December 28, 2019). We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. LONG-TERM DEBT Jun 27, 2020 Dec 28, 2019 (In Millions) Effective Interest Rate Amount Amount Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020 — % $ — $ 700 Three-month LIBOR plus 0.35%, due May 2022 1.82 % 800 800 Fixed-rate senior notes: 1.85%, due May 2020 — % — 1,000 2.45%, due July 2020 2.48 % 1,750 1,750 1.70%, due May 2021 1.78 % 500 500 3.30%, due October 2021 2.98 % 2,000 2,000 2.35%, due May 2022 1.95 % 750 750 3.10%, due July 2022 2.69 % 1,000 1,000 4.00%, due December 2022¹ 3.11 % 379 382 2.70%, due December 2022 2.28 % 1,500 1,500 4.10%, due November 2023 3.21 % 400 400 2.88%, due May 2024 2.31 % 1,250 1,250 2.70%, due June 2024 2.13 % 600 600 3.40%, due March 2025 3.46 % 1,500 — 3.70%, due July 2025 3.48 % 2,250 2,250 2.60%, due May 2026 1.94 % 1,000 1,000 3.75%, due March 2027 3.80 % 1,000 — 3.15%, due May 2027 2.48 % 1,000 1,000 2.45%, due November 2029 2.39 % 2,000 1,250 3.90%, due March 2030 3.94 % 1,500 — 4.00%, due December 2032 2.30 % 750 750 4.60%, due March 2040 4.62 % 750 — 4.80%, due October 2041 3.53 % 802 802 4.25%, due December 2042 2.48 % 567 567 4.90%, due July 2045 3.45 % 772 772 4.10%, due May 2046 2.76 % 1,250 1,250 4.10%, due May 2047 2.63 % 1,000 1,000 4.10%, due August 2047 2.20 % 640 640 3.73%, due December 2047 2.89 % 1,967 1,967 3.25%, due November 2049 3.19 % 2,000 1,500 4.75%, due March 2050 4.76 % 2,250 — 3.10%, due February 2060 3.12 % 1,000 — 4.95%, due March 2060 5.00 % 1,000 — Oregon and Arizona bonds: 2.40%-2.70%, due December 2035 - 2040 2.49 % 423 423 5.00%, due March 2049 2.12 % 138 138 5.00%, due June 2049 2.15 % 438 438 Junior Subordinated Convertible Debentures: 3.25%, due August 2039 — — 372 Total Senior Notes and Other Borrowings 36,926 28,751 Unamortized Premium/Discount and Issuance Costs (375) (529) Hedge Accounting Fair Value Adjustments 1,796 781 Long-term debt 38,347 29,003 Current portion of long-term debt (2,254) (3,695) Total long-term debt $ 36,093 $ 25,308 1 To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $396 million, which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see "Note 12: Derivative Financial Instruments." In the first six months of 2020, we settled $2.1 billion in short-term debt. In the first quarter of 2020, the remaining $372 million of our 2009 Debentures were converted or redeemed, and in the second quarter of 2020, we settled $1.7 billion of our notes due May 2020. In the first six months of 2020, we issued a total of $10.3 billion aggregate principal amount of senior notes. We intend to use the net proceeds from the offering for general corporate purposes, which may include refinancing outstanding debt, funding for working capital and capital expenditures, and repurchasing shares of our common stock. Our senior floating rate notes pay interest quarterly and our senior fixed rate notes pay interest semiannually. We may redeem the fixed rate notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The obligations under the notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and effectively rank junior to all liabilities of our subsidiaries.

Fair Value

Fair Value	6 Months Ended
	Jun. 27, 2020
Fair Value Disclosures [Abstract]
Fair Value [Text Block]	NOTE 10 : FAIR VALUE ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS Jun 27, 2020 Dec 28, 2019 Fair Value Measured and Recorded at Reporting Date Using Fair Value Measured and Recorded at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Cash equivalents: Corporate debt $ — $ 715 $ — $ 715 $ — $ 713 $ — $ 713 Financial institution instruments¹ 3,870 1,591 — 5,461 1,064 408 — 1,472 Government debt² — 666 — 666 — — — — Reverse repurchase agreements — 1,400 — 1,400 — 1,500 — 1,500 Short-term investments: Corporate debt — 1,426 — 1,426 — 347 — 347 Financial institution instruments¹ — 2,096 — 2,096 — 724 — 724 Government debt² — 1,269 — 1,269 — 11 — 11 Trading assets: Corporate debt — 3,605 — 3,605 — 2,848 — 2,848 Financial institution instruments¹ 206 2,304 — 2,510 87 1,578 — 1,665 Government debt² — 6,173 — 6,173 — 3,334 — 3,334 Other current assets: Derivative assets 30 250 — 280 50 230 — 280 Loans receivable³ — 348 — 348 — — — — Marketable equity securities 464 — — 464 450 — — 450 Other long-term investments: Corporate debt — 1,864 — 1,864 — 1,898 — 1,898 Financial institution instruments¹ — 452 — 452 — 825 — 825 Government debt² — 568 — 568 — 553 — 553 Other long-term assets: Derivative assets — 1,679 35 1,714 — 690 16 706 Loans receivable³ — 212 — 212 — 554 — 554 Total assets measured and recorded at fair value $ 4,570 $ 26,618 $ 35 $ 31,223 $ 1,651 $ 16,213 $ 16 $ 17,880 Liabilities Other accrued liabilities: Derivative liabilities $ 48 $ 432 $ — $ 480 $ 3 $ 287 $ — $ 290 Other long-term liabilities: Derivative liabilities — 22 — 22 — 13 — 13 Total liabilities measured and recorded at fair value $ 48 $ 454 $ — $ 502 $ 3 $ 300 $ — $ 303 1 Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions. 2 Level 2 investments consist primarily of U.S. agency notes and non-U.S. government debt. 3 The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. ASSETS MEASURED AND RECORDED AT FAIR VALUE ON A NON-RECURRING BASIS Our non-marketable equity securities, equity method investments, and certain non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an observable price adjustment or impairment is recognized on our non-marketable equity securities during the period, we classify these assets as Level 3 within the fair value hierarchy based on the nature of the fair value inputs. FINANCIAL INSTRUMENTS NOT RECORDED AT FAIR VALUE ON A RECURRING BASIS Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period, grants receivable, loans receivable, reverse repurchase agreements with original maturities greater than three months, and issued debt. As of June 27, 2020, the aggregate carrying value of grants receivable and reverse repurchase agreements with original maturities greater than three months was $301 million ($543 million as of December 28, 2019). The estimated fair value of these financial instruments approximates their carrying value and is categorized as Level 2 within the fair value hierarchy based on the nature of the fair value inputs. As of June 27, 2020, the fair value of our issued debt was $42.5 billion

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	6 Months Ended
	Jun. 27, 2020
Equity [Abstract]
Other Comprehensive Income (Loss) [Text Block]	NOTE 11 : OTHER COMPREHENSIVE INCOME (LOSS) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first six months of 2020 were as follows: (In Millions) Unrealized Holding Gains (Losses) on Derivatives Actuarial Valuation and Other Pension Expenses Translation Adjustments and Other Total Balance as of December 28, 2019 $ 54 $ (1,382) $ 48 $ (1,280) Other comprehensive income (loss) before reclassifications 19 (2) 69 86 Amounts reclassified out of accumulated other comprehensive income (loss) 60 28 — 88 Tax effects (28) (3) (15) (46) Other comprehensive income (loss) 51 23 54 128 Balance as of June 27, 2020 $ 105 $ (1,359) $ 102 $ (1,152)

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 27, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments [Text Block]	NOTE 12 : DERIVATIVE FINANCIAL INSTRUMENTS VOLUME OF DERIVATIVE ACTIVITY Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Jun 27, 2020 Dec 28, 2019 Foreign currency contracts $ 29,129 $ 23,981 Interest rate contracts 14,349 14,302 Other 1,787 1,753 Total $ 45,265 $ 40,036 FAIR VALUE OF DERIVATIVE INSTRUMENTS Jun 27, 2020 Dec 28, 2019 (In Millions) Assets 1 Liabilities 2 Assets 1 Liabilities 2 Derivatives designated as hedging instruments: Foreign currency contracts 3 $ 76 $ 81 $ 56 $ 159 Interest rate contracts 1,713 — 690 9 Total derivatives designated as hedging instruments 1,789 81 746 168 Derivatives not designated as hedging instruments: Foreign currency contracts 3 171 224 179 78 Interest rate contracts 4 149 11 54 Equity contracts 30 48 50 3 Total derivatives not designated as hedging instruments 205 421 240 135 Total derivatives $ 1,994 $ 502 $ 986 $ 303 1 Derivative assets are recorded as other assets, current and non-current. 2 Derivative liabilities are recorded as other liabilities, current and non-current. 3 The majority of these instruments mature within 12 months. AMOUNTS OFFSET IN THE CONSOLIDATED CONDENSED BALANCE SHEETS The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: Jun 27, 2020 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 1,985 $ — $ 1,985 $ (318) $ (1,641) $ 26 Reverse repurchase agreements 1,500 — 1,500 — (1,489) 11 Total assets $ 3,485 $ — $ 3,485 $ (318) $ (3,130) $ 37 Liabilities: Derivative liabilities subject to master netting arrangements $ 397 $ — $ 397 $ (318) $ (79) $ — Total liabilities $ 397 $ — $ 397 $ (318) $ (79) $ — Dec 28, 2019 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 974 $ — $ 974 $ (144) $ (808) $ 22 Reverse repurchase agreements 1,850 — 1,850 — (1,850) — Total assets $ 2,824 $ — $ 2,824 $ (144) $ (2,658) $ 22 Liabilities: Derivative liabilities subject to master netting arrangements $ 262 $ — $ 262 $ (144) $ (72) $ 46 Total liabilities $ 262 $ — $ 262 $ (144) $ (72) $ 46 We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate. DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS The before-tax net gains or losses attributed to cash flow hedges, recognized in other comprehensive income (loss), were $392 million net gains in the second quarter of 2020 and $19 million net gains in the first six months of 2020 ($122 million net gains in the second quarter of 2019 and $151 million net gains in the first six months of 2019). Substantially all of our cash flow hedges were foreign currency contracts for all periods presented. During the first six months of 2020 and 2019, the amounts excluded from effectiveness testing were insignificant. DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Interest rate contracts $ 78 $ 554 $ 1,032 $ 1,039 Hedged items (78) (554) (1,032) (1,039) Total $ — $ — $ — $ — The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows: Line Item in the Consolidated Condensed Balance Sheet in Which the Hedged Item is Included Carrying Amount of the Hedged Item Asset/(Liabilities) Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities) (In Millions) Jun 27, 2020 Dec 28, 2019 Jun 27, 2020 Dec 28, 2019 Long-term debt $ (13,710) $ (12,678) $ (1,713) $ (681) The total notional amount of pay-variable and receive-fixed interest rate swaps was $12.0 billion as of June 27, 2020 and as of December 28, 2019. DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows: Three Months Ended Six Months Ended (In Millions) Location of Gains (Losses) Recognized in Income on Derivatives Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Foreign currency contracts Interest and other, net $ (216) $ (20) $ (62) $ 37 Interest rate contracts Interest and other, net (14) (25) (91) (39) Other Various 225 35 (43) 181 Total $ (5) $ (10) $ (196) $ 179

Contingencies

Contingencies	6 Months Ended
	Jun. 27, 2020
Commitments and Contingencies Disclosure [Abstract]
Contingencies [Text Block]	NOTE 13 : CONTINGENCIES LEGAL PROCEEDINGS We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. European Commission Competition Matter In 2001, the EC commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ($1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision. The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices. We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. In November 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice held oral argument in June 2016. In October 2016, Advocate General Wahl, an advisor to the Court of Justice, issued a non-binding advisory opinion that favored Intel on a number of grounds. The Court of Justice issued its decision in September 2017, setting aside the judgment of the General Court and sending the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. The General Court has appointed a panel of five judges to consider our appeal of the EC’s 2009 decision in light of the Court of Justice’s clarifications of the law. In November 2017, the parties filed initial “Observations” about the Court of Justice’s decision and the appeal and were invited by the General Court to offer supplemental comments to each other’s “Observations,” which the parties submitted in March 2018. Responses to other questions posed by the General Court were filed in May and June 2018. The General Court heard oral argument in March 2020. Pending the final decision in this matter, the fine paid by Intel has been placed by the EC in commercial bank accounts where it accrues interest. Litigation Related to Security Vulnerabilities In June 2017, a Google research team notified us and other companies that it had identified security vulnerabilities (now commonly referred to as “Spectre” and “Meltdown”) that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. On January 3, 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. Numerous lawsuits relating to the Spectre and Meltdown security vulnerabilities, as well as another variant of these vulnerabilities (“Foreshadow”) that has since been identified, have been filed against Intel and, in certain cases, our current and former executives and directors, in U.S. federal and state courts and in certain courts in other countries. As of July 22, 2020, consumer class action lawsuits relating to certain security vulnerabilities publicly disclosed in 2018 were pending in the U.S., Canada, and Israel. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the U.S., numerous individual class action suits filed in various jurisdictions were consolidated in April 2018 for all pretrial proceedings in the U.S. District Court for the District of Oregon. In March 2020, the court granted Intel's motion to dismiss the complaint in that consolidated action but granted plaintiffs leave to file an amended complaint, which they did in April 2020. In Canada, in one case pending in the Superior Court of Justice of Ontario, an initial status conference has not yet been scheduled. In a second case pending in the Superior Court of Justice of Quebec, the court has stayed the case until January 2021. In Israel, both consumer class action lawsuits were filed in the District Court of Haifa. In the first case, the District Court denied the parties' joint motion to stay filed in January 2019, but to date has deferred Intel's deadline to respond to the complaint in view of Intel's pending motion to dismiss in the consolidated proceeding in the U.S. Intel filed a motion to stay the second case pending resolution of the consolidated proceeding in the U.S., and a hearing on that motion has been scheduled for November 2020. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters. In addition to these lawsuits, Intel stockholders filed multiple shareholder derivative lawsuits since January 2018 against certain current and former members of our Board of Directors and certain current and former officers, alleging that the defendants breached their duties to Intel in connection with the disclosure of the security vulnerabilities and the failure to take action in relation to alleged insider trading. The complaints sought to recover damages from the defendants on behalf of Intel. Some of the derivative actions were filed in the U.S. District Court for the Northern District of California and were consolidated, and the others were filed in the Superior Court of the State of California in San Mateo County and were consolidated. The federal court granted defendants' motion to dismiss the consolidated complaint in the federal action in August 2018 on the ground that plaintiffs failed to plead facts sufficient to show they were excused from making a pre-lawsuit demand on the Board. The federal court granted plaintiffs leave to amend their complaint, but subsequently dismissed the cases without prejudice in January 2019 at plaintiffs' request. In August 2018, the California Superior Court granted defendants' motion to dismiss the consolidated complaint in the state court action on the ground that plaintiffs failed to plead facts sufficient to show they were excused from making a pre-lawsuit demand on the Board, but granted plaintiffs leave to amend. The court subsequently granted defendants' motion to dismiss plaintiffs' first, second, and third amended complaints, on the same ground, and in March 2020 granted defendants' motion to dismiss plaintiffs' third amended complaint without granting plaintiffs leave to amend. Plaintiffs filed a motion for reconsideration of the court's final order of dismissal, which is scheduled for hearing on July 31, 2020. Institute of Microelectronics, Chinese Academy of Sciences v. Intel China, Ltd., et al. In February 2018, the Institute of Microelectronics of the Chinese Academy of Sciences (IMECAS) sued Intel China, Ltd., Dell China, Ltd. (Dell) and Beijing JingDong Century Information Technology, Ltd. (JD) for patent infringement in the Beijing High Court. IMECAS alleges that Intel’s Core series processors infringe Chinese patent CN 102956457 (’457 Patent). The complaint demands an injunction and damages of at least RMB 200,000,000 plus the cost of litigation. A trial date is not yet set. In March 2018, Dell tendered indemnity to Intel, which Intel granted in April 2018. JD also tendered indemnity to Intel, which Intel granted in October 2018. In March 2018, Intel filed an invalidation request on the ‘457 patent with the Chinese Patent Reexamination Board (PRB). The PRB held an oral hearing in September 2018 and in February 2019 upheld the validity of the challenged claims. In January 2020, Intel filed a second invalidation request on the ‘457 patent with the PRB. In September 2018 and March 2019, Intel filed petitions with the United States Patent & Trademark Office (USPTO) requesting institution of inter partes review (IPR) of U.S. Patent No. 9,070,719, the U.S. counterpart to the ‘457 patent. The USPTO denied institution of Intel’s petitions in March and October 2019, respectively. In April 2019, Intel filed a request for rehearing and a petition for Precedential Opinion Panel (POP) in the USPTO to challenge the denial of its first IPR petition, and in November 2019 Intel filed a request for rehearing on the second IPR petition. In January 2020, the USPTO denied the POP petition on the first IPR petition. In June 2020, the Patent Trial and Appeal Board denied Intel's rehearing requests on both petitions. In October 2019, IMECAS filed second and third lawsuits, in the Beijing IP Court, alleging infringement of Chinese Patent No. CN 102386226 (‘226 Patent) based on the manufacturing and sale of Intel’s Core i3 microprocessors. Defendants in the second case are Lenovo (Beijing) Co., Ltd. (Lenovo) and Beijing Jiayun Huitong Technology Development Co. Ltd. (BJHT). Defendants in the third case are Intel Corp., Intel China Co., Ltd., the Intel China Beijing Branch, Beijing Digital China Co., Ltd. (Digital China), and JD. Both complaints demand injunctions plus litigation costs and reserve the right to claim damages in unspecified amounts. No proceedings have occurred or are yet scheduled in these lawsuits. In December 2019, Lenovo tendered indemnity to Intel, which Intel granted in March 2020. In July 2020, Intel filed two invalidation requests on the '226 patent with the Chinese PRB. Given the procedural posture and the nature of these cases, the unspecified nature and extent of damages claimed by IMECAS, and uncertainty regarding the availability of injunctive relief under applicable law, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute IMECAS’s claims and intend to vigorously defend against them.

Operating Segments (Tables)

Operating Segments (Tables)	6 Months Ended
	Jun. 27, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Net revenue and operating income (loss) for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Net revenue: Data Center Group Platform $ 6,181 $ 4,553 $ 12,608 $ 9,035 Adjacent 936 430 1,502 850 7,117 4,983 14,110 9,885 Internet of Things IOTG 670 986 1,553 1,896 Mobileye 146 201 400 410 816 1,187 1,953 2,306 Non-Volatile Memory Solutions Group 1,659 940 2,997 1,855 Programmable Solutions Group 501 489 1,020 975 Client Computing Group Platform 8,229 7,925 16,941 15,749 Adjacent 1,267 916 2,330 1,678 9,496 8,841 19,271 17,427 All other 139 65 205 118 Total net revenue $ 19,728 $ 16,505 $ 39,556 $ 32,566 Operating income (loss): Data Center Group $ 3,099 $ 1,800 6,591 $ 3,641 Internet of Things IOTG 70 294 313 545 Mobileye (4) 53 84 121 66 347 397 666 Non-Volatile Memory Solutions Group 322 (284) 256 (581) Programmable Solutions Group 80 52 177 141 Client Computing Group 2,842 3,737 7,067 6,809 All other (712) (1,035) (1,753) (1,885) Total operating income $ 5,697 $ 4,617 $ 12,735 $ 8,791
Revenue from External Customers by Products and Services [Table Text Block]	Disaggregated net revenue for each period was as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Platform revenue DCG platform $ 6,181 $ 4,553 $ 12,608 $ 9,035 IOTG platform 619 891 1,414 1,716 CCG desktop platform 2,368 2,767 5,208 5,653 CCG notebook platform 5,844 5,136 11,701 10,063 CCG other platform 1 16 22 31 33 15,028 13,369 30,962 26,500 Adjacent revenue 2 4,700 3,136 8,594 6,066 Total revenue $ 19,728 $ 16,505 $ 39,556 $ 32,566 1 Includes our tablet and service provider revenue. 2 Includes all of our non-platform products for DCG, IOTG, and CCG such as modem, Ethernet, and silicon photonics, as well as Mobileye, NSG, and PSG products.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 27, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended (In Millions, Except Per Share Amounts) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Net income available to common stockholders $ 5,105 $ 4,179 $ 10,766 $ 8,153 Weighted average shares of common stock outstanding—basic 4,246 4,466 4,256 4,479 Dilutive effect of employee equity incentive plans 38 40 42 46 Dilutive effect of convertible debt — 17 — 18 Weighted average shares of common stock outstanding—diluted 4,284 4,523 4,298 4,543 Earnings per share—basic $ 1.20 $ 0.94 $ 2.53 $ 1.82 Earnings per share—diluted $ 1.19 $ 0.92 $ 2.50 $ 1.79

Contract Liabilities (Tables)

Contract Liabilities (Tables)	6 Months Ended
	Jun. 27, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	(In Millions) Jun 27, 2020 Dec 28, 2019 Prepaid supply agreements $ 1,644 $ 1,805 Other 279 236 Total contract liabilities $ 1,923 $ 2,041
Contract with Customer, Asset and Liability [Table Text Block]	The following table shows the changes in contract liability balances relating to long-term prepaid supply agreements during the first six months of 2020: (In Millions) Prepaid supply agreements balance as of December 28, 2019 $ 1,805 Prepayments utilized (161) Prepaid supply agreements balance as of June 27, 2020 $ 1,644

Other Financial Statement Det_2

Other Financial Statement Details (Tables)	6 Months Ended
	Jun. 27, 2020
Other Financial Statement Details [Abstract]
Schedule of Inventory, Current [Table Text Block]	(In Millions) Jun 27, 2020 Dec 28, 2019 Raw materials $ 903 $ 840 Work in process 6,093 6,225 Finished goods 1,973 1,679 Total inventories $ 8,969 $ 8,744
Interest and Other, Net [Table Text Block]	The components of interest and other, net for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Interest income $ 83 $ 125 $ 176 $ 260 Interest expense (186) (135) (321) (273) Other, net 74 (53) (197) (111) Total interest and other, net $ (29) $ (63) $ (342) $ (124)

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	6 Months Ended
	Jun. 27, 2020
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Charges	Restructuring and other charges by type for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Employee severance and benefit arrangements $ 1 $ 168 $ 106 $ 168 Asset impairment and other charges 8 16 65 16 Total restructuring and other charges $ 9 $ 184 $ 171 $ 184

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 27, 2020
Investments and Cash [Abstract]
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	Jun 27, 2020 Dec 28, 2019 (In Millions) Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Corporate debt $ 3,911 $ 94 $ — $ 4,005 $ 2,914 $ 44 $ — $ 2,958 Financial institution 7,985 24 — 8,009 3,007 15 (1) 3,021 Government debt 2,491 12 — 2,503 560 4 — 564 Total available-for-sale debt investments $ 14,387 $ 130 $ — $ 14,517 $ 6,481 $ 63 $ (1) $ 6,543
Investments Classified by Contractual Maturity Date [Table Text Block]	The fair value of available-for-sale debt investments, by contractual maturity, as of June 27, 2020, was as follows: (In Millions) Fair Value Due in 1 year or less $ 7,763 Due in 1–2 years 1,525 Due in 2–5 years 1,359 Due after 5 years — Instruments not due at a single maturity date 3,870 Total $ 14,517
Investment [Table Text Block]	(In Millions) Jun 27, 2020 Dec 28, 2019 Marketable equity securities $ 464 $ 450 Non-marketable equity securities 3,419 3,480 Equity method investments 18 37 Total $ 3,901 $ 3,967
Gain (Loss) on Securities [Table Text Block]	The components of gains (losses) on equity investments, net for each period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Ongoing mark-to-market adjustments on marketable equity securities $ 165 $ (179) $ 62 $ 74 Observable price adjustments on non-marketable equity securities 58 8 137 16 Impairment charges (51) (39) (193) (62) Sale of equity investments and other¹ 95 380 150 576 Total gains (losses) on equity investments, net $ 267 $ 170 $ 156 $ 604 1 Sale of equity investments and other includes realized gains (losses) on sales of non-marketable equity investments, our share of equity method investee gains (losses) and distributions, and initial fair value adjustments recorded upon a security becoming marketable. Gains and losses for our marketable and non-marketable equity securities during the period were as follows: Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Net gains (losses) recognized during the period on equity securities $ 223 $ (178) $ 83 $ 84 Less: Net (gains) losses recognized during the period on equity securities sold during the period (55) (33) (58) (258) Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date $ 168 $ (211) $ 25 $ (174)

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
	Jun. 27, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	LONG-TERM DEBT Jun 27, 2020 Dec 28, 2019 (In Millions) Effective Interest Rate Amount Amount Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020 — % $ — $ 700 Three-month LIBOR plus 0.35%, due May 2022 1.82 % 800 800 Fixed-rate senior notes: 1.85%, due May 2020 — % — 1,000 2.45%, due July 2020 2.48 % 1,750 1,750 1.70%, due May 2021 1.78 % 500 500 3.30%, due October 2021 2.98 % 2,000 2,000 2.35%, due May 2022 1.95 % 750 750 3.10%, due July 2022 2.69 % 1,000 1,000 4.00%, due December 2022¹ 3.11 % 379 382 2.70%, due December 2022 2.28 % 1,500 1,500 4.10%, due November 2023 3.21 % 400 400 2.88%, due May 2024 2.31 % 1,250 1,250 2.70%, due June 2024 2.13 % 600 600 3.40%, due March 2025 3.46 % 1,500 — 3.70%, due July 2025 3.48 % 2,250 2,250 2.60%, due May 2026 1.94 % 1,000 1,000 3.75%, due March 2027 3.80 % 1,000 — 3.15%, due May 2027 2.48 % 1,000 1,000 2.45%, due November 2029 2.39 % 2,000 1,250 3.90%, due March 2030 3.94 % 1,500 — 4.00%, due December 2032 2.30 % 750 750 4.60%, due March 2040 4.62 % 750 — 4.80%, due October 2041 3.53 % 802 802 4.25%, due December 2042 2.48 % 567 567 4.90%, due July 2045 3.45 % 772 772 4.10%, due May 2046 2.76 % 1,250 1,250 4.10%, due May 2047 2.63 % 1,000 1,000 4.10%, due August 2047 2.20 % 640 640 3.73%, due December 2047 2.89 % 1,967 1,967 3.25%, due November 2049 3.19 % 2,000 1,500 4.75%, due March 2050 4.76 % 2,250 — 3.10%, due February 2060 3.12 % 1,000 — 4.95%, due March 2060 5.00 % 1,000 — Oregon and Arizona bonds: 2.40%-2.70%, due December 2035 - 2040 2.49 % 423 423 5.00%, due March 2049 2.12 % 138 138 5.00%, due June 2049 2.15 % 438 438 Junior Subordinated Convertible Debentures: 3.25%, due August 2039 — — 372 Total Senior Notes and Other Borrowings 36,926 28,751 Unamortized Premium/Discount and Issuance Costs (375) (529) Hedge Accounting Fair Value Adjustments 1,796 781 Long-term debt 38,347 29,003 Current portion of long-term debt (2,254) (3,695) Total long-term debt $ 36,093 $ 25,308

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Jun. 27, 2020
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS Jun 27, 2020 Dec 28, 2019 Fair Value Measured and Recorded at Reporting Date Using Fair Value Measured and Recorded at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Cash equivalents: Corporate debt $ — $ 715 $ — $ 715 $ — $ 713 $ — $ 713 Financial institution instruments¹ 3,870 1,591 — 5,461 1,064 408 — 1,472 Government debt² — 666 — 666 — — — — Reverse repurchase agreements — 1,400 — 1,400 — 1,500 — 1,500 Short-term investments: Corporate debt — 1,426 — 1,426 — 347 — 347 Financial institution instruments¹ — 2,096 — 2,096 — 724 — 724 Government debt² — 1,269 — 1,269 — 11 — 11 Trading assets: Corporate debt — 3,605 — 3,605 — 2,848 — 2,848 Financial institution instruments¹ 206 2,304 — 2,510 87 1,578 — 1,665 Government debt² — 6,173 — 6,173 — 3,334 — 3,334 Other current assets: Derivative assets 30 250 — 280 50 230 — 280 Loans receivable³ — 348 — 348 — — — — Marketable equity securities 464 — — 464 450 — — 450 Other long-term investments: Corporate debt — 1,864 — 1,864 — 1,898 — 1,898 Financial institution instruments¹ — 452 — 452 — 825 — 825 Government debt² — 568 — 568 — 553 — 553 Other long-term assets: Derivative assets — 1,679 35 1,714 — 690 16 706 Loans receivable³ — 212 — 212 — 554 — 554 Total assets measured and recorded at fair value $ 4,570 $ 26,618 $ 35 $ 31,223 $ 1,651 $ 16,213 $ 16 $ 17,880 Liabilities Other accrued liabilities: Derivative liabilities $ 48 $ 432 $ — $ 480 $ 3 $ 287 $ — $ 290 Other long-term liabilities: Derivative liabilities — 22 — 22 — 13 — 13 Total liabilities measured and recorded at fair value $ 48 $ 454 $ — $ 502 $ 3 $ 300 $ — $ 303 1 Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions. 2 Level 2 investments consist primarily of U.S. agency notes and non-U.S. government debt. 3 The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency.

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Jun. 27, 2020
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first six months of 2020 were as follows: (In Millions) Unrealized Holding Gains (Losses) on Derivatives Actuarial Valuation and Other Pension Expenses Translation Adjustments and Other Total Balance as of December 28, 2019 $ 54 $ (1,382) $ 48 $ (1,280) Other comprehensive income (loss) before reclassifications 19 (2) 69 86 Amounts reclassified out of accumulated other comprehensive income (loss) 60 28 — 88 Tax effects (28) (3) (15) (46) Other comprehensive income (loss) 51 23 54 128 Balance as of June 27, 2020 $ 105 $ (1,359) $ 102 $ (1,152)

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 27, 2020
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Jun 27, 2020 Dec 28, 2019 Foreign currency contracts $ 29,129 $ 23,981 Interest rate contracts 14,349 14,302 Other 1,787 1,753 Total $ 45,265 $ 40,036
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	FAIR VALUE OF DERIVATIVE INSTRUMENTS Jun 27, 2020 Dec 28, 2019 (In Millions) Assets 1 Liabilities 2 Assets 1 Liabilities 2 Derivatives designated as hedging instruments: Foreign currency contracts 3 $ 76 $ 81 $ 56 $ 159 Interest rate contracts 1,713 — 690 9 Total derivatives designated as hedging instruments 1,789 81 746 168 Derivatives not designated as hedging instruments: Foreign currency contracts 3 171 224 179 78 Interest rate contracts 4 149 11 54 Equity contracts 30 48 50 3 Total derivatives not designated as hedging instruments 205 421 240 135 Total derivatives $ 1,994 $ 502 $ 986 $ 303 1 Derivative assets are recorded as other assets, current and non-current. 2 Derivative liabilities are recorded as other liabilities, current and non-current. 3 The majority of these instruments mature within 12 months. The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows: Line Item in the Consolidated Condensed Balance Sheet in Which the Hedged Item is Included Carrying Amount of the Hedged Item Asset/(Liabilities) Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities) (In Millions) Jun 27, 2020 Dec 28, 2019 Jun 27, 2020 Dec 28, 2019 Long-term debt $ (13,710) $ (12,678) $ (1,713) $ (681)
Offsetting Assets [Table Text Block]	The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: Jun 27, 2020 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 1,985 $ — $ 1,985 $ (318) $ (1,641) $ 26 Reverse repurchase agreements 1,500 — 1,500 — (1,489) 11 Total assets $ 3,485 $ — $ 3,485 $ (318) $ (3,130) $ 37 Liabilities: Derivative liabilities subject to master netting arrangements $ 397 $ — $ 397 $ (318) $ (79) $ — Total liabilities $ 397 $ — $ 397 $ (318) $ (79) $ — Dec 28, 2019 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 974 $ — $ 974 $ (144) $ (808) $ 22 Reverse repurchase agreements 1,850 — 1,850 — (1,850) — Total assets $ 2,824 $ — $ 2,824 $ (144) $ (2,658) $ 22 Liabilities: Derivative liabilities subject to master netting arrangements $ 262 $ — $ 262 $ (144) $ (72) $ 46 Total liabilities $ 262 $ — $ 262 $ (144) $ (72) $ 46
Offsetting Liabilities [Table Text Block]	The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: Jun 27, 2020 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 1,985 $ — $ 1,985 $ (318) $ (1,641) $ 26 Reverse repurchase agreements 1,500 — 1,500 — (1,489) 11 Total assets $ 3,485 $ — $ 3,485 $ (318) $ (3,130) $ 37 Liabilities: Derivative liabilities subject to master netting arrangements $ 397 $ — $ 397 $ (318) $ (79) $ — Total liabilities $ 397 $ — $ 397 $ (318) $ (79) $ — Dec 28, 2019 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 974 $ — $ 974 $ (144) $ (808) $ 22 Reverse repurchase agreements 1,850 — 1,850 — (1,850) — Total assets $ 2,824 $ — $ 2,824 $ (144) $ (2,658) $ 22 Liabilities: Derivative liabilities subject to master netting arrangements $ 262 $ — $ 262 $ (144) $ (72) $ 46 Total liabilities $ 262 $ — $ 262 $ (144) $ (72) $ 46
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows: Three Months Ended Six Months Ended (In Millions) Location of Gains (Losses) Recognized in Income on Derivatives Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Foreign currency contracts Interest and other, net $ (216) $ (20) $ (62) $ 37 Interest rate contracts Interest and other, net (14) (25) (91) (39) Other Various 225 35 (43) 181 Total $ (5) $ (10) $ (196) $ 179
Interest and other, net [Member] | Fair Value Hedging
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives Three Months Ended Six Months Ended (In Millions) Jun 27, 2020 Jun 29, 2019 Jun 27, 2020 Jun 29, 2019 Interest rate contracts $ 78 $ 554 $ 1,032 $ 1,039 Hedged items (78) (554) (1,032) (1,039) Total $ — $ — $ — $ —

Business Segments (Detail)

Business Segments (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Segment Reporting Information [Line Items]
Net revenue	$ 19,728	$ 16,505	$ 39,556	$ 32,566
Operating Income (Loss)	5,697	4,617	12,735	8,791
Platform
Segment Reporting Information [Line Items]
Net revenue	15,028	13,369	30,962	26,500
Adjacent revenue
Segment Reporting Information [Line Items]
Net revenue	4,700	3,136	8,594	6,066
DCG platform
Segment Reporting Information [Line Items]
Net revenue	6,181	4,553	12,608	9,035
Internet of Things [Member]
Segment Reporting Information [Line Items]
Net revenue	816	1,187	1,953	2,306
Operating Income (Loss)	66	347	397	666
Client Computing Group [Member]
Segment Reporting Information [Line Items]
Net revenue	9,496	8,841	19,271	17,427
Operating Income (Loss)	2,842	3,737	7,067	6,809
Client Computing Group [Member] | Platform
Segment Reporting Information [Line Items]
Net revenue	8,229	7,925	16,941	15,749
Client Computing Group [Member] | Adjacent revenue
Segment Reporting Information [Line Items]
Net revenue	1,267	916	2,330	1,678
Data Center Group [Member]
Segment Reporting Information [Line Items]
Net revenue	7,117	4,983	14,110	9,885
Operating Income (Loss)	3,099	1,800	6,591	3,641
Data Center Group [Member] | Adjacent revenue
Segment Reporting Information [Line Items]
Net revenue	936	430	1,502	850
Internet of Things Group [Member]
Segment Reporting Information [Line Items]
Net revenue	670	986	1,553	1,896
Operating Income (Loss)	70	294	313	545
Mobileye [Member]
Segment Reporting Information [Line Items]
Net revenue	146	201	400	410
Operating Income (Loss)	(4)	53	84	121
Non-Volatile Memory Solutions Group [Member]
Segment Reporting Information [Line Items]
Net revenue	1,659	940	2,997	1,855
Operating Income (Loss)	322	(284)	256	(581)
Programmable Solutions Group [Member]
Segment Reporting Information [Line Items]
Net revenue	501	489	1,020	975
Operating Income (Loss)	80	52	177	141
All other [Member]
Segment Reporting Information [Line Items]
Net revenue	139	65	205	118
Operating Income (Loss)	$ (712)	$ (1,035)	$ (1,753)	$ (1,885)

Product Information (Detail)

Product Information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Revenue from External Customer [Line Items]
Net revenue	$ 19,728	$ 16,505	$ 39,556	$ 32,566
DCG platform
Revenue from External Customer [Line Items]
Net revenue	6,181	4,553	12,608	9,035
IOTG platform
Revenue from External Customer [Line Items]
Net revenue	619	891	1,414	1,716
CCG desktop platform
Revenue from External Customer [Line Items]
Net revenue	2,368	2,767	5,208	5,653
CCG notebook platform
Revenue from External Customer [Line Items]
Net revenue	5,844	5,136	11,701	10,063
Other platform
Revenue from External Customer [Line Items]
Net revenue	16	22	31	33
Platform
Revenue from External Customer [Line Items]
Net revenue	15,028	13,369	30,962	26,500
Adjacent revenue
Revenue from External Customer [Line Items]
Net revenue	$ 4,700	$ 3,136	$ 8,594	$ 6,066

Earnings Per Share (Detail)

Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Earnings Per Share [Abstract]
Net income	$ 5,105	$ 4,179	$ 10,766	$ 8,153
Weighted average shares of common stock outstanding—basic	4,246	4,466	4,256	4,479
Dilutive effect of employee equity incentive plans (shares)	38	40	42	46
Dilutive effect of convertible debt (shares)	0	17	0	18
Weighted average shares of common stock outstanding—diluted	4,284	4,523	4,298	4,543
Earnings per share - Basic (in dollars per share)	$ 1.20	$ 0.94	$ 2.53	$ 1.82
Earnings per share - Diluted (in dollars per share)	$ 1.19	$ 0.92	$ 2.50	$ 1.79

Contract Liabilities (Details)

Contract Liabilities (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 27, 2020	Dec. 28, 2019
Capitalized Contract Cost [Line Items]
Contract with Customer, Liability	$ 1,923	$ 2,041
Contract liability balance, contract termination	1,600
Prepaid supply agreements
Capitalized Contract Cost [Line Items]
Contract with Customer, Liability	1,644	1,805
Contract with Customer, Liability, Revenue Recognized	(161)
Other
Capitalized Contract Cost [Line Items]
Contract with Customer, Liability	$ 279	$ 236

Other Financial Statement Det_3

Other Financial Statement Details Inventories (Details) - USD ($) $ in Millions	Jun. 27, 2020	Dec. 28, 2019
Inventory, Net [Abstract]
Raw materials	$ 903	$ 840
Work in process	6,093	6,225
Finished goods	1,973	1,679
Total inventories	$ 8,969	$ 8,744

Other Financial Statement Det_4

Other Financial Statement Details Interest and Other, Net (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Other Nonoperating Income (Expense) [Abstract]
Interest income	$ 83	$ 125	$ 176	$ 260
Interest expense	(186)	(135)	(321)	(273)
Other, net	74	(53)	(197)	(111)
Total interest and other, net	(29)	(63)	(342)	(124)
Interest Costs Capitalized	$ 87	$ 120	$ 170	$ 245

Restructuring and Other Charg_3

Restructuring and Other Charges (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
2020 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Employee severance and benefit arrangements	$ 1		$ 106
Asset impairment and other charges	8		65
Total restructuring and other charges	$ 9		$ 171
INTC Restructuring Program Three
Restructuring Cost and Reserve [Line Items]
Employee severance and benefit arrangements		$ 168		$ 168
Asset impairment and other charges		16		16
Total restructuring and other charges		$ 184		$ 184

Investments, Trading Assets (De

Investments, Trading Assets (Detail) - Debt Securities [Member] - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Debt Securities, Trading, Unrealized Gain (Loss)	$ 347	$ 117	$ 183	$ 99
Unrealized Gain (Loss) on Derivatives	$ 251	$ 102	$ 204	$ (104)

Investments, Available-for-Sale

Investments, Available-for-Sale Debt Investments (Detail) - USD ($) $ in Millions	Jun. 27, 2020	Dec. 28, 2019
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	$ 14,387	$ 6,481
Gross Unrealized Gains	130	63
Gross Unrealized Losses	0	(1)
Fair Value	14,517	6,543
Due in 1 year or less	7,763
Due in 1–2 years	1,525
Due in 2–5 years	1,359
Due after 5 years	0
Instruments not due at a single maturity date	3,870
Corporate Debt Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	3,911	2,914
Gross Unrealized Gains	94	44
Gross Unrealized Losses	0	0
Fair Value	4,005	2,958
Fixed Income Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	7,985	3,007
Gross Unrealized Gains	24	15
Gross Unrealized Losses	0	(1)
Fair Value	8,009	3,021
Government Debt [Member]
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	2,491	560
Gross Unrealized Gains	12	4
Gross Unrealized Losses	0	0
Fair Value	$ 2,503	$ 564

Investments, Equity Investments

Investments, Equity Investments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 28, 2019
Schedule of Investments [Line Items]
Marketable Securities	$ 464		$ 464		$ 450
Cost Method Investments	3,419		3,419		3,480
Equity Method Investments	18		18		37
Equity Investments	3,901		3,901		$ 3,967
Mark to market on marketable equity securities1	165	$ (179)	62	$ 74
Observable price adjustments on non-marketable	58	8	137	16
Impairments	(51)	(39)	(193)	(62)
Other Net Equity Investments	95	380	150	576
Gain (Loss) on Investments	267	170	156	604
Net gains (losses) recognized during the period on equity securities	223	(178)	83	84
Less: Net (gains) losses recognized during the period on equity securities sold during the period	(55)	(33)	(58)	(258)
Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date	$ 168	(211)	$ 25	(174)
IM Flash Technologies, LLC [Member]
Schedule of Investments [Line Items]
Equity Method Investments		$ 1,300		$ 1,300

Investments, Equity Method Inve

Investments, Equity Method Investments (Detail) - USD ($) $ in Millions	Jun. 27, 2020	Dec. 28, 2019	Jun. 29, 2019
Schedule of Equity Method Investments [Line Items]
Carrying Value, equity method investments	$ 18	$ 37
Marketable Securities	$ 464	$ 450
IM Flash Technologies, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Ownership Percentage			49.00%
Carrying Value, equity method investments			$ 1,300

Acquisitions and Divestitures (

Acquisitions and Divestitures (Details) - USD ($) $ in Millions	May 04, 2020	Jun. 27, 2020	Dec. 28, 2019
Business Acquisition [Line Items]
Goodwill		$ 26,943	$ 26,276
Moovit
Business Acquisition [Line Items]
Goodwill	$ 638
Intangible assets	331
Business Combination, Consideration Transferred	$ 915

Borrowings Borrowings, Narrativ

Borrowings Borrowings, Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Mar. 28, 2020	Jun. 27, 2020	Dec. 28, 2019
Debt Instrument [Line Items]
Short-term debt	$ 2,254,000,000		$ 2,254,000,000	$ 3,695,000,000
Short-term debt settled			2,100,000,000
Convertible debentures | 2009 Debentures
Debt Instrument [Line Items]
Redemption of debentures		$ 372,000,000
Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount	10,300,000,000		10,300,000,000
Senior Notes | Senior Notes due May 2020
Debt Instrument [Line Items]
Redemption of debentures	1,700,000,000
Commercial Paper
Debt Instrument [Line Items]
Authorization to borrow	$ 10,000,000,000		$ 10,000,000,000

Borrowings, Long-term Debt (Det

Borrowings, Long-term Debt (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Mar. 28, 2020	Jun. 27, 2020	Dec. 28, 2019
Debt Instrument [Line Items]
Amount		$ 36,926	$ 28,751
Unamortized Premium/Discount and Issuance Costs		(375)	(529)
Long-term debt		38,347	29,003
Current portion of long-term debt		(2,254)	(3,695)
Total long-term debt		36,093	25,308
Notional amount		45,265	40,036
Fair Value Hedging | Interest Rate Swap
Debt Instrument [Line Items]
Hedge Accounting Fair Value Adjustments	$ 781	$ 1,796
Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020
Debt Instrument [Line Items]
Effective Interest Rate		0.00%
Amount		$ 0	700
Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020 | LIBOR
Debt Instrument [Line Items]
Variable rate		0.08%
Floating-rate senior notes: Three-month LIBOR plus 0.35%, due May 2022
Debt Instrument [Line Items]
Effective Interest Rate		1.82%
Amount		$ 800	800
Floating-rate senior notes: Three-month LIBOR plus 0.35%, due May 2022 | LIBOR
Debt Instrument [Line Items]
Variable rate		0.35%
1.85%, due May 2020
Debt Instrument [Line Items]
Interest rate		1.85%
Effective Interest Rate		0.00%
Amount		$ 0	1,000
2.45%, due July 2020
Debt Instrument [Line Items]
Interest rate		2.45%
Effective Interest Rate		2.48%
Amount		$ 1,750	1,750
1.70%, due May 2021
Debt Instrument [Line Items]
Interest rate		1.70%
Effective Interest Rate		1.78%
Amount		$ 500	500
3.30%, due October 2021
Debt Instrument [Line Items]
Interest rate		3.30%
Effective Interest Rate		2.98%
Amount		$ 2,000	2,000
2.35%, due May 2022
Debt Instrument [Line Items]
Interest rate		2.35%
Effective Interest Rate		1.95%
Amount		$ 750	750
3.10%, due July 2022
Debt Instrument [Line Items]
Interest rate		3.10%
Effective Interest Rate		2.69%
Amount		$ 1,000	1,000
4.00%, due December 2022¹
Debt Instrument [Line Items]
Interest rate		4.00%
Effective Interest Rate		3.11%
Amount		$ 379	382
4.00%, due December 2022¹ | Cross Currency Interest Rate Contract
Debt Instrument [Line Items]
Notional amount		$ 396
2.70%, due December 2022
Debt Instrument [Line Items]
Interest rate		2.70%
Effective Interest Rate		2.28%
Amount		$ 1,500	1,500
4.10%, due November 2023
Debt Instrument [Line Items]
Interest rate		4.10%
Effective Interest Rate		3.21%
Amount		$ 400	400
2.88%, due May 2024
Debt Instrument [Line Items]
Interest rate		2.88%
Effective Interest Rate		2.31%
Amount		$ 1,250	1,250
2.70%, due June 2024
Debt Instrument [Line Items]
Interest rate		2.70%
Effective Interest Rate		2.13%
Amount		$ 600	600
3.40%, due March 2025
Debt Instrument [Line Items]
Interest rate		3.40%
Effective Interest Rate		3.46%
Amount		$ 1,500	0
3.70%, due July 2025
Debt Instrument [Line Items]
Interest rate		3.70%
Effective Interest Rate		3.48%
Amount		$ 2,250	2,250
2.60%, due May 2026
Debt Instrument [Line Items]
Interest rate		2.60%
Effective Interest Rate		1.94%
Amount		$ 1,000	1,000
3.75%, due March 2027
Debt Instrument [Line Items]
Interest rate		3.75%
Effective Interest Rate		3.80%
Amount		$ 1,000	0
3.15%, due May 2027
Debt Instrument [Line Items]
Interest rate		3.15%
Effective Interest Rate		2.48%
Amount		$ 1,000	1,000
2.45%, due November 2029
Debt Instrument [Line Items]
Interest rate		2.45%
Effective Interest Rate		2.39%
Amount		$ 2,000	1,250
3.90%, due March 2030
Debt Instrument [Line Items]
Interest rate		3.90%
Effective Interest Rate		3.94%
Amount		$ 1,500	0
4.00%, due December 2032
Debt Instrument [Line Items]
Interest rate		4.00%
Effective Interest Rate		2.30%
Amount		$ 750	750
4.60%, due March 2040
Debt Instrument [Line Items]
Interest rate		4.60%
Effective Interest Rate		4.62%
Amount		$ 750	0
4.60%, due March 2040
Debt Instrument [Line Items]
Interest rate		4.80%
Effective Interest Rate		3.53%
Amount		$ 802	802
4.25%, due December 2042
Debt Instrument [Line Items]
Interest rate		4.25%
Effective Interest Rate		2.48%
Amount		$ 567	567
4.90%, due July 2045
Debt Instrument [Line Items]
Interest rate		4.90%
Effective Interest Rate		3.45%
Amount		$ 772	772
4.10%, due May 2046
Debt Instrument [Line Items]
Interest rate		4.10%
Effective Interest Rate		2.76%
Amount		$ 1,250	1,250
4.10%, due May 2047
Debt Instrument [Line Items]
Interest rate		4.10%
Effective Interest Rate		2.63%
Amount		$ 1,000	1,000
4.10%, due August 2047
Debt Instrument [Line Items]
Interest rate		4.10%
Effective Interest Rate		2.20%
Amount		$ 640	640
3.73%, due December 2047
Debt Instrument [Line Items]
Interest rate		3.73%
Effective Interest Rate		2.89%
Amount		$ 1,967	1,967
3.25%, due November 2049
Debt Instrument [Line Items]
Interest rate		3.25%
Effective Interest Rate		3.19%
Amount		$ 2,000	1,500
4.75%, due March 2050
Debt Instrument [Line Items]
Interest rate		4.75%
Effective Interest Rate		4.76%
Amount		$ 2,250	0
3.10%, due February 2060
Debt Instrument [Line Items]
Interest rate		3.10%
Effective Interest Rate		3.12%
Amount		$ 1,000	0
4.95%, due March 2060
Debt Instrument [Line Items]
Interest rate		4.95%
Effective Interest Rate		5.00%
Amount		$ 1,000	0
2.40%-2.70%, due December 2035 - 2040
Debt Instrument [Line Items]
Effective Interest Rate		2.49%
Amount		$ 423	423
2.40%-2.70%, due December 2035 - 2040 | Minimum
Debt Instrument [Line Items]
Interest rate		2.40%
2.40%-2.70%, due December 2035 - 2040 | Maximum
Debt Instrument [Line Items]
Interest rate		2.70%
5.00%, due March 2049
Debt Instrument [Line Items]
Interest rate		5.00%
Effective Interest Rate		2.12%
Amount		$ 138	138
5.00%, due June 2049
Debt Instrument [Line Items]
Interest rate		5.00%
Effective Interest Rate		2.15%
Amount		$ 438	438
3.25%, due August 2039
Debt Instrument [Line Items]
Interest rate		3.25%
Effective Interest Rate		0.00%
Junior Subordinated Convertible Debentures		$ 0	$ 372

Fair Value (Detail)

Fair Value (Detail) - USD ($) $ in Millions	Jun. 27, 2020	Dec. 28, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	$ 1,500	$ 1,850
Trading assets, Fair Value Disclosure	12,288	7,847
Derivative assets, Fair Value Disclosure	1,985	974
Derivative liabilities, Fair Value Disclosure	397	262
Cost Method Investments	3,419	3,480
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	31,223	17,880
Liabilities, Fair Value Disclosure	502	303
Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants & loans Receivable, Reverse repurchase agreements, CV	301	543
Short-term and Long-term Debt, Fair Value	42,500	30,600
Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	3,605	2,848
Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	2,510	1,665
Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	6,173	3,334
Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	464	450
Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	1,400	1,500
Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	715	713
Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	5,461	1,472
Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	666	0
Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,426	347
Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	2,096	724
Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,269	11
Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	280	280
Loans receivable, Fair Value Disclosure	348	0
Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,864	1,898
Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	452	825
Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	568	553
Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	1,714	706
Loans receivable, Fair Value Disclosure	212	554
Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	480	290
Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	22	13
Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	4,570	1,651
Liabilities, Fair Value Disclosure	48	3
Level 1 [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 1 [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	206	87
Level 1 [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 1 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	464	450
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 1 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	3,870	1,064
Level 1 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	30	50
Loans receivable, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Loans receivable, Fair Value Disclosure	0	0
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	48	3
Level 1 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	26,618	16,213
Liabilities, Fair Value Disclosure	454	300
Level 2 [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	3,605	2,848
Level 2 [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	2,304	1,578
Level 2 [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	6,173	3,334
Level 2 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	1,400	1,500
Level 2 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	715	713
Level 2 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,591	408
Level 2 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	666	0
Level 2 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,426	347
Level 2 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	2,096	724
Level 2 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,269	11
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	250	230
Loans receivable, Fair Value Disclosure	348	0
Level 2 [Member] | Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,864	1,898
Level 2 [Member] | Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	452	825
Level 2 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	568	553
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	1,679	690
Loans receivable, Fair Value Disclosure	212	554
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	432	287
Level 2 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	22	13
Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	35	16
Liabilities, Fair Value Disclosure	0	0
Level 3 [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 3 [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 3 [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 3 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 3 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Loans receivable, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	35	16
Loans receivable, Fair Value Disclosure	0	0
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	$ 0	$ 0

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 28, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months			$ 48
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (1,152)		(1,152)		$ (1,280)
Other comprehensive income (loss)	389	$ 191	128	$ 352
Unrealized holding gains (losses) on available-for-sale investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	105		105		54
Other comprehensive income (loss) before reclassifications			19
Amounts reclassified out of accumulated other comprehensive income (loss)			60
Tax effects			(28)
Other comprehensive income (loss)			51
Unrealized holding gains (losses) on derivatives [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(1,359)		(1,359)		(1,382)
Other comprehensive income (loss) before reclassifications			(2)
Amounts reclassified out of accumulated other comprehensive income (loss)			28
Tax effects			(3)
Other comprehensive income (loss)			23
Actuarial gains (losses) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	102		102		48
Other comprehensive income (loss) before reclassifications			69
Amounts reclassified out of accumulated other comprehensive income (loss)			0
Tax effects			(15)
Other comprehensive income (loss)			54
Foreign currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	$ (1,152)		(1,152)		$ (1,280)
Other comprehensive income (loss) before reclassifications			86
Amounts reclassified out of accumulated other comprehensive income (loss)			88
Tax effects			(46)
Other comprehensive income (loss)			$ 128

Derivative Financial Instrume_3

Derivative Financial Instruments (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 27, 2020	Mar. 28, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 28, 2019
Notional Disclosures [Abstract]
Notional amount	$ 45,265			$ 45,265		$ 40,036
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,985			1,985		974
Derivative Assets Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0			0		0
Derivative Assets Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	1,985			1,985		974
Derivative Assets, Financial Instruments Not Offset in the Balance Sheet	(318)			(318)		(144)
Derivative Assets, Cash Collateral Not Offset in the Balance Sheet	(1,641)			(1,641)		(808)
Derivative Assets Subject to Master Netting Arrangements, Net Amount	26			26		22
Reverse Repurchase Agreements, Gross Amounts Recognized	1,500			1,500		1,850
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet	0			0		0
Reverse Repurchase Agreements, Net Amount Presented in the Balance Sheet	1,500			1,500		1,850
Reverse Repurchase Agreements, Financial Instruments Not Offset in the Balance Sheet	0			0		0
Reverse Repurchase Agreements, Cash Collateral Not Offset in the Balance Sheet	(1,489)			(1,489)		(1,850)
Reverse Repurchase Agreements, Net Amount	11			11		0
Total Assets, Gross Amounts Recognized	3,485			3,485		2,824
Total Assets, Gross Amounts Offset in the Balance Sheet	0			0		0
Total Assets, Net Amounts Presented in the Balance Sheet	3,485			3,485		2,824
Total Assets, Financial Instruments, Not Offset in the Balance Sheet	(318)			(318)		(144)
Total Assets, Cash and Non Cash Collateral, Not Offset in the Balance Sheet	(3,130)			(3,130)		(2,658)
Total Assets, Net Amount	37			37		22
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	397			397		262
Derivative Liabilities Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0			0		0
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	397			397		262
Derivative Liabilities, Financial Instruments Not Offset in the Balance Sheet	(318)			(318)		(144)
Derivative Liabilities, Cash Collateral Not Offset in the Balance Sheet	(79)			(79)		(72)
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount	0			0		46
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(78)		$ (554)	(1,032)	$ (1,039)
Net Change In Unrealized Gain (Loss) Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge	0		0	0	0
Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,994			1,994		986
Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	502			502		303
Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,789			1,789		746
Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	81			81		168
Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(5)		(10)	(196)	179
Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	205			205		240
Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	421			421		135
Foreign currency contracts
Notional Disclosures [Abstract]
Notional amount	29,129			29,129		23,981
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net [Abstract]
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	392		122	19	151
Foreign currency contracts | Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	76			76		56
Foreign currency contracts | Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	81			81		159
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Interest and other, net [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(216)		(20)	(62)	37
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	171			171		179
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	224			224		78
Interest rate contracts
Notional Disclosures [Abstract]
Notional amount	14,349			14,349		14,302
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	78		554	1,032	1,039
Interest rate contracts | Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,713			1,713		690
Interest rate contracts | Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	0			0		9
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Interest and other, net [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(14)		(25)	(91)	(39)
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	4			4		11
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	149			149		54
Other
Notional Disclosures [Abstract]
Notional amount	1,787			1,787		1,753
Other | Not Designated as Hedging Instrument [Member] | Various [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	225		$ 35	(43)	$ 181
Other | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	30			30		50
Other | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	48			48		3
Interest Rate Swap | Fair Value Hedging
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives		$ (781)		(1,796)
Interest Rate Swap | Long-term Debt | Fair Value Hedging
Derivative [Line Items]
Derivative, Amount of Hedged Item	12,000			12,000
Derivative, Fair Value, Net	$ (13,710)			(13,710)		$ (12,678)
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives		$ (681)		$ (1,713)

Contingencies (Detail)

Contingencies (Detail) - 1 months ended May 31, 2009 € in Billions, $ in Billions	EUR (€)	USD ($)
EC Fine [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Paid Value	€ 1.1	$ 1.4